Pacira BioSciences Inc (PCRX) Earnings Call Presentation
PCRX-201 | Innovative gene therapy targeting underlying cause of osteoarthritis Jonathan Slonin, Chief Medical Officer April 2025 Forward-looking statements and where to find additional information Patients suffering from knee OA say it impacts5 Any statements in this presentation about Pacira's future expectations, plans, trends, outlook, projections and prospects, and other statements containing the words "believes," "anticipates," "plans," "estimates," "expects," "intends," "may," "will," "would," "could ...